REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVene, Inc., a clinical-stage medical device company dedicated to developing interventional solutions for chronic venous insufficiency (CVI), announced today ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVene Inc. announced today that it has received Breakthrough Device Designation by the FDA for the company’s BlueLeaf ® Endovenous Valve Formation ...

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The US-based clinical stage ...